标签平衡的目的是防止贴错。那么如果按照FDA cGMP(针对于制剂,原理当然适合于原料药),有足够的措施保证的话(比如:对每一个包装贴签进行检查),个人认为其实不需要进行标签数量平衡(中间体和原料药)。
参见:
§211.125 Labeling issuance.(a) Strict control shall be exercised over labeling issued for use in drug product labeling operations. (b) Labeling materials issued for a batch shall be carefully examined for identity and conformity to the labeling specified in the master or batch production records. (c) Procedures shall be used to reconcile the quantities of labeling issued, used, and returned, and shall require evaluation of discrepancies found between the quantity of drug product finished and the quantity of labeling issued when such discrepancies are outside narrow preset limits based on historical operating data. Such discrepancies shall be investigated in accordance with §211.192. Labeling reconciliation is waived for cut or roll labeling if a 100-percent examination for correct labeling is performed in accordance with §211.122(g)(2). Labeling reconciliation is also waived for 360° wraparound labels on portable cryogenic medical gas containers. |